RSS Statement

Most of the information found on this website comes from RSS Feeds. It is an automated task that provides the information to you. We try to limit items that are duplicates, but with many feeds this can be difficult. Since the owner of this website also has MS and is legally blind this service was necessary to keep the website running with as much automation as possible. Volunteers help from time to time but many have disabilities themselves. We thank you for visiting us and hope that MSC can be of service to you and your loved ones.

Most Read Website

This site is designed to inform and support those with Multiple Sclerosis. It is not a comprehensive medical guide to the disease. This information is taken from many different resources. The writings on this site are not intended to diagnose nor treat. The ideas and writings seen here are not to be substituted for the medical advice of a practicing physician. Prayer is a wonderful treatment but when God does not heal someone it may be necessary for medical treatment of MS

Also see:

MSC Disclaimer 

EasyBlog - Latest Blogs Module

11 October 2019
From the Web
By Angela Betsaida B. Laguipo, BSNOct 11 2019Over the past years, the human microbiome has gained immense popularity due to its role in shaping one’s health. It is essential for human development, nutrition, and immunity. That’s why many studies have...
08 October 2019
SYRACUSE, NY – Syracuse has the nation’s highest rate of Multiple Sclerosis, according to a new study.An analysis of medical claims by the Blue Cross Blue Shield Association found the multiple diagnosis rate in Syracuse in 2017 was 45 per 10,000 comm...
08 October 2019
M.S. Views & News
April 2019Pharmacy benefit manager have a significant behind-the-scenes impact in determining drug costs and patients’ access to medications. Some experts think pharmacy benefit managers need to move their business model away from securing rebates fr...
08 October 2019
Several years ago, Stefan Weitz was diagnosed with an incurable autoimmune disease: Multiple Sclerosis. He faced the prospect of being confined to a wheelchair and early death—neither of which jived with running a global software team on four contine...
08 October 2019
Biogen, Inc. BIIB  has a strong position in the Multiple Sclerosis (MS) market with a wide range of products including Avonex, Tysabri, Tecfidera and Plegridy. It is working on strengthening its position further by bringing new treatments. In Novembe...

National MS Society News

14 October 2019

This is a list of all national news for the National MS Society.

Who's Online

We have 167 guests and no members online